Edinburgh Research Explorer

Correction: Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

Research output: Contribution to journalArticle

  • G N Hortobagyi
  • S M Stemmer
  • H A Burris
  • Y S Yap
  • G S Sonke
  • S Paluch-Shimon
  • M Campone
  • K Petrakova
  • K L Blackwell
  • E P Winer
  • W Janni
  • S Verma
  • P Conte
  • C L Arteaga
  • S Mondal
  • F Su
  • M Elmeliegy
  • C Germa
  • J O'Shaughnessy

Related Edinburgh Organisations

Original languageEnglish
JournalAnnals of oncology
Early online date13 Aug 2019
DOIs
Publication statusE-pub ahead of print - 13 Aug 2019

ID: 110374962